In Q2, net revenue rose to SEK 173.9m from SEK 150.5m (+15.6%), with organic growth of 15.8%. Profitability improved meaningfully: gross margin expanded to 67.1% (from 62.5%) and operating profit jumped to SEK 20.5m (from SEK 7.1m), lifting operating margin to 11.8% (from 4.7%). Orders increased 4.1% to 77.0k, and EPS rose to SEK 0.75 (from SEK 0.26), signaling strong, broad-based business momentum.
The key mechanism here is not top-line growth by itself, but proof that scale is finally converting into incremental margin. A ~500 bps+ gross margin step-up suggests either better product mix, pricing discipline, or input-cost relief; if any of those are durable, the earnings power of the business is materially higher than the revenue line alone implies. In the next 1-3 months, the stock can re-rate if management frames this as repeatable rather than a one-off quarter, because small-cap growth names often trade more on margin inflection than absolute revenue growth.
The nuance is that order growth lagging revenue growth slightly can be a tell: the business may be harvesting existing demand rather than accelerating demand creation. That matters because gross margin gains from mix/pricing are usually easier to defend than gains from volume leverage, but they are also more fragile if competitors respond with discounting. If this is a branded or specialized product business, the second-order winner is the supply chain and any adjacent peers with lower margins; if it is a software-like model, the market may still be underestimating how quickly EBITDA can compound from here.
Contrarianly, the consensus may be over-indexing on the headline margin expansion and underweighting the absence of evidence that growth is re-accelerating. The bull case is structural operating leverage over 6-18 months; the bear case is that gross margin normalizes while opex creeps back, compressing the current earnings surprise. What would falsify the thesis is a sequential decline in gross margin or a step-down in order growth over the next two quarters, which would signal the current profitability is not repeatable.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
strongly positive
Sentiment Score
0.55